ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,800Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 609

$1.06M Total Retail Price of All Prescriptions

Rank: 17 out of 609

729 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 729 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

14% of this provider’s 729 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 13,757 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 586 520 1 1
FUROSEMIDE 579 538 2 4
METOPROLOL TARTRATE 516 465 3 9
AMLODIPINE BESYLATE 470 436 4 2
WARFARIN SODIUM 417 401 5 8
OMEPRAZOLE 332 318 6 3
LEVOTHYROXINE SODIUM 325 290 7 7
HYDROCODONE-ACETAMINOPHEN 281 235 S3 8 30
ENALAPRIL MALEATE 262 220 9 32
CLOPIDOGREL 227 198 10 17
METFORMIN HCL 226 177 11 10
POTASSIUM CHLORIDE 225 202 12 40
LISINOPRIL 221 193 13 12
ATENOLOL 216 189 14 27
QUETIAPINE FUMARATE 203 173 15 116
TRAMADOL HCL 200 158 16 39
AZITHROMYCIN 191 156 17 67
CIPROFLOXACIN HCL 189 152 18 42
SERTRALINE HCL 189 183 18 61
DIOVAN HCT 188 176 20 31
PREDNISONE 183 156 21 26
ZOLPIDEM TARTRATE 179 136 22 18
FAMOTIDINE 173 169 23 50
DIOVAN 165 137 24 15
DIGOXIN 156 152 25 33
NEXIUM 154 138 26 13
PLAVIX 153 131 27 25
OXYCODONE-ACETAMINOPHEN 136 123 S2 28 44
AMLODIPINE BESYLATE-BENAZEPRIL 133 133 29 88
DONEPEZIL HCL 126 123 30 22
TAMSULOSIN HCL 123 123 31 11
ALLOPURINOL 121 112 32 75
METOPROLOL SUCCINATE 117 107 33 5
GABAPENTIN 116 106 34 21
ATORVASTATIN CALCIUM 113 105 35 6
CYMBALTA 108 52 36 76
GLYBURIDE-METFORMIN HCL 102 90 R 37 149
CITALOPRAM HBR 101 84 38 112
HYDROCHLOROTHIAZIDE 93 80 39 20
NAMENDA 91 87 40 36
CRESTOR 91 75 40 16
TRIAMTERENE-HCTZ 87 75 42 204
LIDODERM 86 84 43 81
GLIPIZIDE 81 63 44 169
ADVAIR DISKUS 81 62 44 28
LACTULOSE 78 56 46 109
FENTANYL 74 72 S2 47 66
CARVEDILOL 73 66 48 14
RAMIPRIL 73 69 48 46
METOLAZONE 73 64 48 316
NOVOLOG FLEXPEN 72 59 51 122
COMBIVENT 71 66 52 269
PRAVASTATIN SODIUM 71 61 52 35
SEROQUEL 70 58 54 276
MOMETASONE FUROATE 69 67 55 291
MIRTAZAPINE 69 69 55 58
PROAIR HFA 67 45 57 57
CARBIDOPA-LEVODOPA 64 64 58 49
CEPHALEXIN 63 55 59 196
IBUPROFEN 63 46 59 103
MECLIZINE HCL 63 55 59 144
CELEBREX 62 60 62 60
PAROXETINE HCL 62 55 62 123
TRAZODONE HCL 62 41 62 113
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 57 65 77
LANTUS 58 41 66 82
PHENYTOIN SODIUM EXTENDED 58 33 66 206
SPIRIVA 57 57 68 43
JANTOVEN 57 49 68 459
NITROFURANTOIN MONO-MACRO 56 53 70 131
PANTOPRAZOLE SODIUM 56 39 70 29
ESCITALOPRAM OXALATE 56 35 70 91
LIPITOR 56 51 70 47
PROPRANOLOL HCL 56 53 70 312
DILTIAZEM HCL 56 56 70 377
CYCLOBENZAPRINE HCL 55 49 R 76 95
AMIODARONE HCL 52 52 77 158
TRAMADOL HCL-ACETAMINOPHEN 52 18 77 102
LOSARTAN-HYDROCHLOROTHIAZIDE 52 38 77 69
LOVASTATIN 51 42 80 199
LANTUS SOLOSTAR 50 49 81 63
FLUOXETINE HCL 50 46 81 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.